Background/Aims: High-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) poses therapeutic challenges in elderly subjects. Due to lack of efficient drug therapy, plantbased bioactive peptides have been studied as alternative strategy in NAFLD and for less toxicity in elderly. To mimic fatty liver in aging conditions, researchers highly commended the genetically engineered strains SAMP8 (senescence-accelerated mice prone 8). However, there is a paucity of reports about the anti-steatosis effects of bioactive peptides against fatty liver development under a combined action of high-fat diet exposure and aging process. This study was conducted to evaluate the activity of DIKTNKPVIF peptide synthesized from alcalase-generated potato protein hydrolysate (PH), on reducing HFD-driven and steatosisassociated proinflammatory reaction in ageing model. Methods: Five groups of six-month- old SAMP8 mice (n=4, each) were fed either a normal chow (NC group) for 14 weeks upon sacrifice, or induced with a 6-week HFD feeding, then treated without (HCO group) or with an 8-week simultaneous administration of peptide (HPEP group), protein (HPH group) or probucol (HRX group). Liver organs were harvested from each group for histological analysis and immunoblot assay. Results: In contrast to NC, extensive fat accumulation was visualized in the liver slides of HCO. Following the trends of orally administered PH, intraperitoneally injected peptide reduces hepatic fat deposition and causes at protein level, a significant decrease in HFD-induced proinflammatory mediators p-p38 MAPK, FGF-2, TNF-α, IL-6 with concomitant reactivation of AMPK. However, p-Foxo1 and PPAR-α levels were slightly changed. Conclusion: Oral supplementation of PH and intraperitoneal injection of derived bioactive peptide alleviate proinflammatory reaction associated with hepatosteatosis development in elderly subjects, through activation of AMPK.
Introduction
Aging and high-fat hypernutrition are known as major risk factors for various systemic and organ-specific disorders, including nonalcoholic fatty liver disease (NAFLD) [1] . These combined factors may promote excess fat deposition in liver or steatosis in more than 5% of hepatic parenchyma, in the context of little amount of alcohol consumption and in absence of existing hepatic pathologies [2] . Hepatosteatosis, the early reversible stage of NAFLD, may progress to nonalcoholic steatohepatitis (NASH) and furtherly to fibrosis, cirrhosis and hepatocellular carcinoma (HCC) [2, 3] , with subsequent health and social burden [4] . To study fatty liver and potential therapeutic strategy our lab has successfully developed various dietary murine models and investigated protein hydrolysates from soy or potato with beneficial therapeutic effects [5] [6] [7] . Considering special issues with drug administration in elderly, we purposed in this present work to induce NAFLD in SAMP8 specific strains with HFD and evaluate our natural ingredients. Other authors have proposed SAMP8 as the best SAM (senescence-accelerated mice) strains for NAFLD study [8, 9] . Exposing SAMP8 to HFD can properly mimic the disease pathogenesis. In fact, in non-ageing models, our lab's previous animal experiments evidenced that, compared to control group feeding standard chow, young C57BL/6 mice fed a HFD presented abnormal hepatic fat accumulation, increased hepatic level of proinflammatory response [7] .
NAFLD progression to NASH (nonalcoholic steatohepatitis) relies greatly on underlying proinflammatory events, which can be fueled by HFD [10, 11] . Exposure to HFD then activates key hepatic proinflammatory mediators such as p38 MAP kinase, TNF-α, IL-6 [12] , with concomitant impairment of AMPK, a major signaling molecule controlling the pathways of hepatic metabolic homeostasis [13] . Liver-specific re-activation of AMPK suppresses NAFLD onset [13] . AMPK inhibition can be signaled by hepatic inflammatory stimuli [10, 14] . Any therapeutic attempt to decrease inflammatory stimuli in aging liver in conjunction with enhancing or restoring the function of cellular energy sensing regulators such as AMPK could show beneficial effects against NAFLD development. However, despite recent pharmacological advances, there is still no available recommended drug therapy for NAFLD patients, including elderly [15] . However, associated risk factors for NALFD are managed with cholesterol lowering agents or specific drugs for associated diseases, alongside with lifestyle and diet changes [4, 16, 17] . Alternative strategies using plant bioactive compounds were found to retard the development of NAFLD.
Bioactive compounds comprise nature-based ingredients such as nutraceuticals, peptides, antioxidants, with evidence of health-promoting effects via their activities on biological and physicochemical processes such as lipid metabolism control, energy expenditure [18, 19] . In dietary experimental models [7, 20, 21] , bioactive peptides from popular food crops, including soy and potato, have been studied for their anti-steatosis effects. Dietary intake of amino acids or peptides was found to modulate important molecular metabolic sensors such as AMPK. For instance, administration of Black soy peptides (BSP, 10%) was able to restore the decreased phospho-AMPK level in white adipose tissue (WAT) of diet-induced obese (DIO) mice fed a HFD [21] . Therefore, considering that HFD-induced inflammation in liver can impair AMPK function related to cellular metabolic homeostasis, we sought to investigate whether our already-tested lipolysis-activating PH and its derived bioactive peptide [5] , by interfering with HFD-driven proinflammatory response, could restore the activity of molecular regulators involving in hepatic lipid metabolism; thus would alleviate NAFLD burden in aging model. On this basis, we have designed a fourteen-week experimental study with SAM8 mice feeding a normal chow diet (NC) or a HFD and then without (HCO) or with simultaneous administration of peptide (HPEP), protein hydrolysate (HPH) or probucol, a hypocholesterolaemic drug (HRX).
We have found that either oral administration of PH or intraperitoneal (i.p.) injection of our peptide reduced lipid droplets pool in SAMP8 mice fed a HFD, in parallel with a significant decrease in protein levels of p-p38 MAPK, FGF-2, TNF-α, IL-6 and reactivation of AMPK. Cumulative data suggest our bioactive peptide as a potential hepato-protective ingredient capable of counteracting hepatosteatosis-related proinflammatory state responsible for NAFLD progression in elderly.
Materials and Methods

Materials
The primary antibodies FGF-2 (sc-79), IL-6 (sc-7920), MMP-9 (sc-6841), MMP-2 (sc-13595), PPAR-α (sc-9000), α-tubulin (sc-5286), β-actin (sc-47778), TNF-α (sc-1350) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); AMPKα (#2532), p-AMPKα (Thr172) (#2535), p-FoxO1 (#9464), p38 MAPK (#9212) and p-p38 MAPK (Thr180/Tyr182) (#9211) from Cell Signaling Technology (Danvers, MA, USA). All other reagents and chemicals, including Probucol, were from Sigma Aldrich (St. Louis, MO, USA) unless otherwise mentioned.
Potato-extracted protein hydrolysate and bioactive peptide
We followed established methods for preparation and purification of potato-extracted Protein Hydrolysate (PH) [4] . Crude potato protein was purchased from Han-Sient Co. (Taipei, Taiwan) and Alcalase from Novo Nordisk A/S (Copenhagen, Denmark). Following the manufacturer's instructions, a reaction mixture was prepared with crude potato protein (2.5%) subjected to hydrolysis during 2h by alcalase enzyme (equal to 1% of crude protein weight). An amount of 1 mL product mixture was obtained from an aqueous combination of protein hydrolysate with o-phthaldialdeyde (OPA) solution, and then incubated for two minutes at room temperature. Then, the product absorbance was obtained by ultraviolet-visible spectrophotometry (Shimazu, UVmini-1240) at wavelength of 340 nm. The product mixture generated a hydrolysate (~81% protein), having a degree of hydrolysis higher than 9.5% and exhibiting lipolysisstimulating activity on 3T3-L1 cell lines. Different membrane cut-off filters were used to assess the molecular sizes of PH fragments: 55% of the resultant products weighting less than 1000 Da, 40% between 1000 and 6000 Da, and only 5% more than 6000 Da.
MB Mission Biotech Co. (Taipei, Taiwan) provided a commercial service for characterization process, including amino acids composition and peptide synthesis. Fractionation work was done by using reverse phase high performance liquid chromatography (RP-HPLC). The resultant fractions were characterized by using tandem mass spectrometry total ion current (MS-MS-TIC) for peptide sequence identification. The ions series for chosen peptides from the MS-MS-TIC chromatogram were analyzed against protein database (UniProt, Solanum tuberosum) by TurboSequest software (Thermo Fisher Scientific, MA, USA). Data analysis revealed DIKTNKPVIF peptide which showed sequence homogeneity with patatin (Accession number Q2MY50) of potato protein. The amino acids (AA) composition of PH and the bioactive peptide is found in Fig. 1 .
DIKTNKPVIF peptide was synthesized at the N-terminus and purified by RP-HPLC to 95% of purity. The synthesis was performed using standard F-moc (9-fluorenylmethoxycarbonyl) chemistry by an ABI 433A, fully automated and programmable Peptide Synthesizer (Applied Biosystems, Foster city, CA, USA), in solid-phase peptide synthesis (SPPS) monitored with the software packages provided with the Taiwan) approved the animal experiments through IACUC-100-12 protocol. SAMP8 (n = 20) having 6 months of age were purchased from the National Laboratory Animal Centre in Taipei (Taiwan). Mice were individually housed per cage on a 12-hour light-darkness cycle in a room at 22-24 °C and 45-55 % humidity. Reverse osmosis treated water was given ad libitum to all groups. NC group fed a normal chow (Rodent Diet 5010 purchased from LabDiet, St. Louis, MO, USA) for 14 weeks upon sacrifice. Remaining groups were induced with a 6-week HFD feeding, then followed without (HCO group) or with an 8-week simultaneous administration of peptide (HPEP group: i.p. 15 mg/kg/day BW), protein (HPH group: 50 mg/kg/day BW, oral gavage) or Probucol (HRX group: 500 mg/kg/day BW, oral gavage). At the end of the experimental period, mice were sacrificed. After overnight fasting, mice were successively anesthetized using ether in a chemical safety hood, euthanized by carbon dioxide asphyxiation, then decapitated. The HFD formula, 58Y1, purchased from LabDiet (St. Louis, MO, USA) consisted of 20.1% calories from carbohydrates (33% from sucrose), 18.3 % calories from protein and 60.9 % calories from fat (88% from lard and 12% from soybean oil). BSA was used as vehicle. Probucol, a well-known drug, was used in this study as positive control for its role to slow down NASH progression in patients [22] .
Masson's trichrome staining (MS)
Collected hepatic tissues from each group were soaked in 10% formalin during two weeks, dehydrated by consecutive immersion in alcohols (75%, 85%, 90%, and 100%, for 5 min each) and embedded in paraffin wax. Paraffin-embedded tissue blocks were sectioned into 0.2-μm-thick slides, then deparaffinized by a three-time immersion into xylene for 5 min each, followed by rehydration with successive soaking in 100%, 90%, 85%, and 75% alcohols for 5 min each. Masson's trichrome dye was added for 5 min to tissue slides. Hepatic morphological changes were analyzed and photomicrographs taken with a Zeiss Axiophot microscope.
Tissue protein extraction
Hepatic tissues of four mice from each group were collected and washed 3 times in phosphate-buffered saline solution. Proper amount of lysis buffer (100 mg/ mL) was added to each sample. The samples were homogenized, positioned on ice for 30 min, followed by centrifugation process with 12, 000 rpm for 40 min at 4°C. The collected supernatants were stored in microcentrifuge tubes at −80 °C for further experiments. The buffer was prepared with 0.02M Tris, 0.002M EDTA, 0.05M 2-mercaptoethanol, 10 % glycerol, phosphatase inhibitor 1μl per ml and protease inhibitor per 10ml 
SAMP8
Lowry protein assay Bovine serum albumin (BSA) solution (0.5 mg/ml) was prepared by mixing proper amount of water with 2mg/mL of BSA in a tube. A standard curve was obtained on the basis of ascended grades of protein standards (0, 0.1, 0.2, 0.3, 0.4, 0.5 mg/ml) by using the diluted BSA solution (0.5 mg/ml). In brief, a two-step reaction had taken place. First, the alkaline copper tartrate solution was prepared by mixing proper volume of Na 2 CO 3 (2% w/v) in NaOH (0.1 M) with CuSO 4 .5H 2 O (1% w/v) and Na-K tartrate (1% w/v) with a ratio of 98:1:1. A tetradentate complex with four peptide bonds and one central atom of copper was formed in an alkaline medium as resultant of a 10-minute reaction mixture at room temperature (RT) between protein and copper ions (Cu 2+ and Cu
1+
) found in the alkaline copper tartrate solution. Second, by adding folin's reagent for a 30-minute reaction at RT, phosphomolybdic-phosphotungstic complex was reduced by Cu 1+ ions, with the consequence of generating reduced species characterized by a blue color and an absorbance of 405-750 nm. Afterwards, an Elisa reader was used to determine the OD value at a wavelength of 750nm.
Western blotting
Protein product concentrations from liver tissue extracts were assessed by using Lowry protein assay method. Aliquots from each tissue sample were mixed with appropriate amount of 5× loading dye, then heated for five minutes at 95°C. The loaded samples were electrophoretically separated in 8%, 10% or 12 % sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under constant current of 75 V from a power source. Afterwards, another sequence of electrophoresis using 50 V current for 3 h resulted in proteins transfer to polyvinylidene difluoride (PVDF) membranes (GE Healthcare UK Ltd). Then membranes were incubated with 3% bovine serum albumin (BSA) in Tris-buffered saline (TBS). Specific primary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added to selected membranes for antigen-antibody reaction. Then, Horseradish peroxidase−labelled secondary antibodies were applied accordingly. Membranes soaking in ECL reagent were photographed with Fujifilm LAS-3000 (GE Healthcare Life sciences). Image J software from NIH (USA) was used for data quantification.
Statistical analysis
Data shown are expressed as the means ± SD of three (3) independent experiments. To compare multiple groups, statistical analysis was done by one-way ANOVA based on a general linear model (LSD), using SPSS statistical software (version 12.0). Statistical significance was considered at the level of p<0.05. 
Results
Bioactive
DIKTNKPVIF peptide activates hepatic AMPK signaling in order to ameliorate liver steatosis in HDF-fed SAMP8 mice
To investigate important molecular regulators involving in hepatic lipid metabolism, we assessed the protein expression of p-AMPK, PPARα, p-FoxO1 (Fig. 3) . HFD exposure resulted in a significant inhibition of hepatic AMPK activity in HCO (P < 0.001), contrary to a high presence of AMPK in liver samples from the group fed a standard chow. Surprisingly, HFDinduced impairment of AMPK signaling was not followed by significant decrease in some of its targets such as PPARα or p-FoxO1. With negligible impact on the aforementioned targets, the treatments in HPEP and HPH significantly reactivate AMPK function which was impaired by HFD exposure. These data suggest not only a direct and intrinsic implication of AMPK in fatty balance in our current model, but a role for our compounds to upregulate this important hepatic metabolic sensor. 
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DIKTNKPVIF attenuates proinflammatory reaction in HDF-fed SAMP8 mice through targeting p-p38 MAP kinase
Persistent proinflammatory response fuels fatty liver development and progression. Next, we assessed the expression of main proteins involved in hepatic proinflammatory reaction such as p-p38, FGF-2, TNF-α, IL-6, MMP-9 and MMP-2. These aforementioned markers were found to be highly elevated in HCO, compared to NC group. Following the trend of PH supplementation, i.p. injection of our peptide significantly decreased p-p38 (P < 0.01, HPEP vs HCO) and FGF-2 (Fig. 4) , TNF-α and IL-6 (Fig. 5) , with moderate reduction in MMP-9 and MMP-2 expression even though both were upregulated by HFD (Fig. 6) .
Discussion
This present study where we investigated DIKTNKPVIF peptide from potato protein hydrolysate aligns with our lab's previous successful work. We have already studied the effects of a bioactive peptide from soy (VHVV) in young mice model of fatty liver [7] . Presently, we have purposed to investigate how effective a potato protein hydrolysate and its derived peptide, a novel compound, can help mitigate NAFLD development in aging model. Following our previous study with a crude protein hydrolysate from potato [6] , here we report the results of DIKTNKPVIF peptide synthesized from the original lipolysisactivating PH, highlighting its efficacy to reduce HFD-driven fat deposition and associated proinflammatory response related to NAFLD development in SAMP8 aging mice. Our current model combined two main features: western-like HFD hypernutrition and ageing background. Our present SAMP8 mice model of NAFLD was successfully developed, even though we did not consider measuring and reporting whole body growth parameters or serum and hepatic biochemical indexes such as TG, glucose, adiponectin. The novelty for our present study resides in our attempt for the first time to mimic NAFLD in SAMP8 strains. Previous reports highly recommended senescence-accelerated mice prone 8 as suitable ageing-related model to study NAFLD [8, 9] . But, to the extent of our current knowledge, no record on HFD-fed SAMP8 mice to study NAFLD is available. However, two recent studies compared HFD intake with standard chow feeding on hepatic changes in SAMP10) [23, 24] . Their results showed that high-fat diet promoted lipid droplets accumulation in the livers of SAMP10 mice, contrary to normal chow feeding [23] . The same observation was confirmed by histopathological analysis of liver sections from SAMP8 mice groups in our model (Fig. 2) . Steatosis is a consequence of elevated hepatocellular free fatty acids (FFA) pool size created from a disequilibrium between the formation of dietary and de-novo-synthesis FFA, and expenditure through β-oxidation or export. Resulting lipid droplets are formed from triglyceride (TG) [25] [26] [27] . AMPK is a master regulator of both lipid and carbohydrate metabolism in liver [15] . In our study, its function was inhibited by HFD and AMPK became unable to maintain energy balance by itself and by signaling other important targets such as PPAR-α and FoxO1 (Fig. 3) . However, treatment with our potato extracts significantly upregulated the expression of the phosphorylated form of AMPK, which was drastically dropped by HFD. The same trends were followed with no statistical significance by PPAR-α, a lipid regulator, and by FoxO1, a regulator of glucose homeostasis, downstream mediator for insulin signaling (Fig. 3) . Therefore, a positive effect of our peptide and protein hydrolysate against NAFLD was by enabling lipid metabolism through activation of AMPK in livers of HPEP and HPH groups, in parallel with alleviating hepatocyte proinflammatory reaction.
In fact, our data show a significant decrease by our peptide in the hepatic protein level of proinflammatory and mitogenic p-p38 and FGF-2 (Fig. 4) , of TNF-α and IL-6 (Fig. 5 ), but with no significant reduction in MMP-9 and MMP-2 (Fig. 6) ; whereas all these markers were found highly expressed in HCO liver samples. Even though MMP-9 and MMP-2 were highly upregulated in HCO liver samples, their presence denotes rather a proinflammatory response than profibrogenic activity [28, 29] , because there is no evidence of collagen deposition as revealed by histological data (Fig 2) . Above findings are consistent with previous publications from our lab related to VHVV, a bioactive peptide derived from flavourzyme-generated soy protein isolate hydrolysate (F-SPIH) which reduced hepatosteatosis and associated inflammatory events in HFD-induced fatty changes in young C57BL/6 mice. Through i.p. administration, VHVV was able to decrease hepatic inflammatory mediators such as TNF-α and IL-6 [7] .
Back to our current work, Western Blot analysis of liver samples indicates that p38 MAPK, another inflammatory activator of TNF-α and IL-6 [30] and well-known clinical biomarker for NAFLD, was found to be highly activated in HCO group, but its activation was impeded by the peptide at almost the same extent as PH (Fig. 4) . Together with TNF-α and IL-6 (Fig. 5) , the expression of p-p38 indicates a high proinflammatory response in HFD-fed mice, which the peptide administration helped to attenuate. On the other hand, its high expression in HCO liver suggest a mitogenic role in connection with Hepatic Stellate Cells (HSC) activation as result of hepatic lipid deposition [31, 32] . However, contrary to our data and other published work, an inhibitory role to hepatic lipogenesis was reported to be associated with an activation of p38 MAPK signaling pathway [33] . Interestingly, p38 has become a target for drug development [17] . Furthermore, in connection with proinflammatory and mitogenic activity related to HSC activation, a role of the cytokine FGF-2 has been studied [34, 35] . Here we report that our peptide reduced significantly HFD-induced increase of fibroblast growth factor 2 in SAMP8 mice liver (Fig. 4) .
In conclusion, the activity of DIKTNKPVIF bioactive peptide and its parent protein PH in matter of alleviating proinflammatory events underlying HFD-induced hepatic steatosis in elderly was investigated in SAMP8 aging mice feeding a HFD. High-fat diet-promoted changes such as liver steatosis, inflammatory damage, were attenuated by either peptide or parent protein hydrolysate administration which not only enhances lipid metabolism through AMPK activation, but alleviates hepatic proinflammatory response as well. Despite some limitations aforementioned within the discussion section, we conclude that PH and synthesized biopeptide can be used respectively as hepatoprotective agent for counteracting underlying proinflammatory events responsible for hepatosteatosis development and progression in elderly.
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